The latest policy and advocacy updates related to the field of clinical and translational science.
The November elections brought a shift in the balance of power to Washington with Joe Biden winning the White House for the Democrats and control of the Senate hinging on two January runoff elections in Georgia. Shortly after the election, the Republican leadership of the Senate Appropriations Committee released the twelve annual appropriations bills as “Chairman’s Marks”. This action was solely intended to facilitate negotiations with the House of Representatives (which previously passed its FY 2021 appropriations bills) on final spending measures for the year. The federal government is currently operating on a continuing appropriations resolution that is set to expire on December 11th and lawmakers appear interested in finalizing FY 2021 appropriations before the 116th Congress adjourns at the end of the year.
Below, please find an overview of key funding items from the Senate FY 2021 appropriations measures: